Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

946 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender and acute myocardial infarction: is there a different response to thrombolysis?
Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM. Woodfield SL, et al. Among authors: white hd. J Am Coll Cardiol. 1997 Jan;29(1):35-42. doi: 10.1016/s0735-1097(96)00449-4. J Am Coll Cardiol. 1997. PMID: 8996292 Free article. Clinical Trial.
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, Morris D, Aylward P, Woodlief LH, Topol EJ. Barbash GI, et al. Among authors: white hd. J Am Coll Cardiol. 1995 Nov 1;26(5):1222-9. doi: 10.1016/0735-1097(95)00299-5. J Am Coll Cardiol. 1995. PMID: 7594035 Free article. Clinical Trial.
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Mak KH, et al. Among authors: white hd. J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6. J Am Coll Cardiol. 1997. PMID: 9207639 Free article. Clinical Trial.
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Mahaffey KW, et al. Among authors: white hd. J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x. J Am Coll Cardiol. 1997. PMID: 9385883 Free article. Clinical Trial.
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK, White HD, Granger CB, Simes RJ, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ. Metz BK, et al. Among authors: white hd. J Am Coll Cardiol. 1998 Jun;31(7):1493-8. doi: 10.1016/s0735-1097(98)00138-7. J Am Coll Cardiol. 1998. PMID: 9626825 Free article. Clinical Trial.
Effect of age on outcome with primary angioplasty versus thrombolysis.
Holmes DR Jr, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Holmes DR Jr, et al. Among authors: white hd. J Am Coll Cardiol. 1999 Feb;33(2):412-9. doi: 10.1016/s0735-1097(98)00579-8. J Am Coll Cardiol. 1999. PMID: 9973021 Free article. Clinical Trial.
946 results